A Driving Performance Evaluation Study of TS-142 Using a Driving Simulator in Non-elderly and Elderly Healthy Subjects
Latest Information Update: 17 Jan 2022
At a glance
- Drugs Vornorexant (Primary) ; Zopiclone
- Indications Insomnia
- Focus Pharmacodynamics
- Sponsors Taisho Pharmaceutical
- 12 Jan 2022 Status changed from recruiting to completed.
- 19 Jan 2021 Status changed from not yet recruiting to recruiting.
- 08 Jan 2021 New trial record